Oxytocin receptor and HER2 interactions in breast cancer
Liu, H.; Liu, L.; Moeller, A.; Muttenthaler, M.
Show abstract
Breast cancer affects women globally, with HER2 being one of the most aggressive subtypes. Despite advances in HER2-targeted therapies, many patients fail to respond to such treatments. In search of alternative therapeutic targets, we investigated the role of the oxytocin (OT) and oxytocin receptor (OTR) signalling system in HER2+ breast cancer. Survival analysis of HER2 subtype breast cancer patients revealed high OTR expression correlating with significantly improved relapse-free survival. OTR overexpression or knockdown in HER2+ SK-BR-3 cells decreased or increased cell viability, respectively. HER2 was downregulated in OTR-overexpressing cells, which could contribute to the decreased Pertuzumab efficacy. Importantly, HER2 was internalised upon OT treatment and interacted with OTR to form OTR-HER2 complexes. OT treatment furthermore induced a transient inhibition of HER2 phosphorylation without affecting the total HER2 protein levels. In addition, OT inhibited ERK1/2 phosphorylation but enhanced Akt phosphorylation, linked to increased cell viability. In summary, this work describes a novel HER2-OTR interaction and mechanism, expanding our understanding of HER2 cancer biology that might lead to new prognostic and therapeutic opportunities centred around the OT/OTR signalling system for patients suffering from HER2+ breast cancer.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Selective Impact of ALK and MELK Inhibition on ERα Stability and Cell Proliferation in Cell Lines Representing Distinct Molecular Phenotypes of Breast Cancer 96%
- S100A8/A9 mediate the reprograming of normal mammary epithelial cells induced by dynamic cell-cell interactions with adjacent breast cancer cells. 94%
- Oncogenic signaling inhibits c-FLIP expression and promotes cancer cell survival during ECM-detachment 94%
Similar papers in this journal
- TPX2 expression promotes sensitivity to dasatinib in breast cancer by activating the YAP transcriptional signaling. 94%
- PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and Tamoxifen in a luminal A breast cancer model 93%
- MET variants with activating N-lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation 92%
Similar papers in this journal
- MDM2 Inhibition in Combination with Endocrine Therapy and CDK4/6 Inhibition for the Treatment of ER-Positive Breast Cancer. 93%
- Circulating neutrophils from patients with early breast cancer have distinct subtype-dependent phenotypes 92%
- Multiomic profiling of metastatic potential in estrogen receptor-positive human epidermal growth factor-negative breast cancer 92%
Similar papers in this journal
- Protein profiling of breast carcinomas reveals expression of immune-suppressive factors and signatures relevant to patient outcome 95%
- HERC1 regulates breast cancer cells migration and invasion 94%
- Suppression of Ovarian Cancer Cell Proliferation is Associated with Upregulation of Cell-Matrix Adhesion Programs and Integrin-β4-Induced Cell Protection from Cisplatin. 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.